Dosing in phase II trial of Alzheimer's vaccine suspended.
Senior
Kathryn
K
D000544:Alzheimer Disease / Q000188:drug therapy*; D023582:Alzheimer Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D016229:Amyloid beta-Peptides / Q000008:administration & dosage* / Q000009:adverse effects; D017322:Clinical Trials, Phase II as Topic / Q000379:methods; D006801:Humans; D007115:Immunization Schedule
C437846:AN-1792; D023582:Alzheimer Vaccines; D016229:Amyloid beta-Peptides